Stocktoria
Definium Therapeutics, Inc. DFTX
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-05-04
Chart by TradingView
1/9
Piotroski F — financial health
1.64
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$166.3M | -$103.9M | -$93.9M | -$66.3M | -$93.9M |
| Net income | -$183.8M | -$108.7M | -$95.7M | -$56.8M | -$93.0M |
| Operating cash flow | -$131.6M | -$79.1M | -$64.4M | -$50.1M | -$45.8M |
| Total assets | $440.1M | $302.2M | $124.5M | $170.0M | $164.0M |
| Total liabilities | $107.8M | $60.7M | $46.4M | $19.1M | $12.3M |
| Shareholders' equity | $332.3M | $241.4M | $78.1M | $150.9M | $151.7M |
| Ratios | |||||
| Return on assets | -41.8% | -36.0% | -76.9% | -33.4% | -56.7% |
| Return on equity | -55.3% | -45.0% | -122.5% | -37.6% | -61.3% |
| Debt / equity | 0.12× | 0.09× | 0.18× | — | — |
| Current ratio | 6.29 | 7.25 | 3.22 | 8.16 | 13.18 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 175,490 | $3.3M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.64 (grey)
- Working capital / assets 0.801
- Retained earnings / assets -1.324
- EBIT / assets -0.378
- Equity / liabilities 3.084
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001813814 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.